drug that inhibits the enzymatic conversion of testosterone to dihydrotestosterone; used to treat benign prostate hyperplasia.
FDA-approved finasteride treatment for BPH.
A medication prescribed to alleviate the symptoms of BPH (benign prostatic hyperplasia) but which also has anti-neoplastic activity as well as preventative effects.
Brand name of a drug using (finasteride) that reportedly shrinks the prostate gland in the treatment of BPH and PCa.
finasteride as an FDA approved treatment for BPH.
The brand name for finestaride approved for the treatment of BPH.
The brand name of a medication (manufactured by Merck), containing 5 milligrams of finasteride, for the treatment of benign pro-static hyperplasia (BPH) or enlarged prostate.